Pfizer & Abu Dhabi DoH unite to foster clinical trials capabilities

Pfizer & Abu Dhabi DoH unite to foster clinical trials capabilities

Officials from DoH Abu Dhabi and Pfizer during the signing ceremony.

Abu Dhabi’s regulative body of the healthcare sector, Department of Health – Abu Dhabi (DoH) has entered into a partnership with American drugmaker Pfizer to develop national competencies and clinical research capacity in the emirate.

According to the statement, the partnership will focus on improving clinical trial conduct as well as research and medical processes in Abu Dhabi.

Pfizer will assist the Department of Health in developing a training curriculum that is specialized in advancing the early phase of clinical trials and drug development programs.

The partnership underscores the emirate’s ongoing efforts to improve its digital health system and promote healthcare innovation.

As per the statement, “Through this collaboration, Pfizer seeks to train up to 150 clinical researchers who will also have an opportunity of research mentorship support by Pfizer research partner within two years supporting DoH aim of reaching 500 qualified clinical researchers by 2025 through various collaborations and initiatives.”

Dr. Jamal Mohammed Al Kaabi Undersecretary – DoHAbu Dhabi

“Under our wise leadership, DoH is committed to positioning Abu Dhabi as an incubator for innovation in the field of life sciences and as a leading healthcare destination in the world. We do this by providing